Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: a patent review (2014-present)

.

Source: Expert Opinion on Therapeutic Patents - December 14, 2020 Category: Drugs & Pharmacology Authors: Xin Sun Shan Xu Zunhua Yang Pengwu Zheng Wufu Zhu Source Type: research